Cancer Risk after Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer Risk after Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy

Published:2014-05-22 Issue:6 Volume:9 Page:1066-1073
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

van den Brand Jan A.J.G.,van Dijk Peter R.,Hofstra Julia M.,Wetzels Jack F.M.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference29 articles.

1. Chapter 7: Idiopathic membranous nephropathy

2. Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials

3. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis a 20-year followup study

4. Bladder and Kidney Cancer Following Cyclophosphamide Therapy for Non-Hodgkin's Lymphoma

5. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key Points in Managing PLA2R-Associated Membranous Nephropathy;Kidney International Reports;2024-08

2. Comparison of tacrolimus with or without prednisone therapy in primary membranous nephropathy: a retrospective clinical study;Scientific Reports;2024-06-20

3. Ten tips on immunosuppression in primary membranous nephropathy;Clinical Kidney Journal;2024-04-29

4. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study;International Urology and Nephrology;2024-04-20

5. Urine albumin-to-creatinine ratio diurnal variation rate predicts outcomes in idiopathic membranous nephropathy;Clinical and Experimental Nephrology;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3